Page last updated: 2024-10-19

phenylacetic acid and Glioma

phenylacetic acid has been researched along with Glioma in 6 studies

phenylacetic acid : A monocarboxylic acid that is toluene in which one of the hydrogens of the methyl group has been replaced by a carboxy group.

Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)

Research Excerpts

ExcerptRelevanceReference
" To examine whether aromatic fatty acids are potential imaging agents for PPARalpha or tumors in general, [11C]phenylacetic acid (PAA) and [18F]fluorophenyl-acetic acid (FPAA) were synthesized and evaluated in EMT-6 tumor bearing mice and 9L-Glioma tumor bearing rats and compared to [11C]acetate."3.71Investigations into tumor accumulation and peroxisome proliferator activated receptor binding by F-18 and C-11 fatty acids. ( Jonson, SD; Welch, MJ, 2002)
"Because primary brain tumors are highly reminiscent of the immature central nervous system, these neoplasms should be equally vulnerable."1.29Selective activity of phenylacetate against malignant gliomas: resemblance to fetal brain damage in phenylketonuria. ( Hudgins, WR; Liu, L; Myers, CE; Oldfield, EH; Ram, Z; Samid, D; Shack, S; Walbridge, S, 1994)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (66.67)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Samid, D2
Ram, Z1
Hudgins, WR1
Shack, S1
Liu, L2
Walbridge, S1
Oldfield, EH1
Myers, CE1
Prasanna, P1
Thibault, A1
Chang, SM1
Kuhn, JG1
Robins, HI1
Schold, SC1
Spence, AM1
Berger, MS1
Mehta, MP1
Bozik, ME1
Pollack, I1
Schiff, D1
Gilbert, M1
Rankin, C1
Prados, MD1
Burzynski, SR1
Jonson, SD1
Welch, MJ1
Tian, Y1
Yang, C1
Zhao, C1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Phase II Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Progressive or Recurrent CNS Malignancy[NCT00006450]Phase 2120 participants Interventional2000-11-30Completed
Phase I and Pharmacokinetic Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Refractory Malignancy[NCT00001565]Phase 135 participants Interventional1996-12-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for phenylacetic acid and Glioma

ArticleYear
Phase II study of phenylacetate in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Female; Glioma; Humans; Male; Middle Aged; Neop

1999

Other Studies

5 other studies available for phenylacetic acid and Glioma

ArticleYear
Selective activity of phenylacetate against malignant gliomas: resemblance to fetal brain damage in phenylketonuria.
    Cancer research, 1994, Feb-15, Volume: 54, Issue:4

    Topics: Animals; Brain; Brain Neoplasms; Female; Glioma; Humans; Mevalonic Acid; Mice; Mice, Nude; Phenylace

1994
Selective activity of phenylacetate against malignant gliomas: resemblance to fetal brain damage in phenylketonuria.
    Cancer research, 1994, Feb-15, Volume: 54, Issue:4

    Topics: Animals; Brain; Brain Neoplasms; Female; Glioma; Humans; Mevalonic Acid; Mice; Mice, Nude; Phenylace

1994
Selective activity of phenylacetate against malignant gliomas: resemblance to fetal brain damage in phenylketonuria.
    Cancer research, 1994, Feb-15, Volume: 54, Issue:4

    Topics: Animals; Brain; Brain Neoplasms; Female; Glioma; Humans; Mevalonic Acid; Mice; Mice, Nude; Phenylace

1994
Selective activity of phenylacetate against malignant gliomas: resemblance to fetal brain damage in phenylketonuria.
    Cancer research, 1994, Feb-15, Volume: 54, Issue:4

    Topics: Animals; Brain; Brain Neoplasms; Female; Glioma; Humans; Mevalonic Acid; Mice; Mice, Nude; Phenylace

1994
Lipid metabolism as a target for brain cancer therapy: synergistic activity of lovastatin and sodium phenylacetate against human glioma cells.
    Journal of neurochemistry, 1996, Volume: 66, Issue:2

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Ce

1996
Efficacy of antineoplastons A10 and AS2-1.
    Mayo Clinic proceedings, 1999, Volume: 74, Issue:6

    Topics: Antineoplastic Agents; Benzeneacetamides; Clinical Trials as Topic; Dose-Response Relationship, Drug

1999
Investigations into tumor accumulation and peroxisome proliferator activated receptor binding by F-18 and C-11 fatty acids.
    Nuclear medicine and biology, 2002, Volume: 29, Issue:2

    Topics: Acetates; Animals; Carbon Radioisotopes; Female; Fluorine Radioisotopes; Glioma; Kidney; Liver; Mamm

2002
[Up regulation of phenylacetate to glioma homeobox gene expression].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2002, Volume: 24, Issue:2

    Topics: Animals; Antimetabolites, Antineoplastic; Gene Expression Regulation, Neoplastic; Genes, Homeobox; G

2002